MULTIMODALITY AGENTS FOR TUMOR IMAGING AND THERAPY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20110223102A1
SERIAL NO

12677381

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

In or GdIII and its method of use for diagnosing, imaging and/or treating hyperproliferative tissue such as tumors. Preferably the photosensitizer is a tumor avid tetrapyrollic photosensitizer, e.g. a porphyrin, chlorin or bacteriochlorin, e.g. pheophorbides and pyropheophorbides. Such conjugates have extreme tumor avidity and can be used to inhibit or completely destroy the tumor by light absoption. The integrin is usually αvβ3, α5β1, αvβ5, α4β1, or α2β1. Preferably, the antagonist is an RGD peptide or another antagonist that may be synthetic such as a 4-{2-(3,4,5,6-tetra-hydropyrimidin-2-ylamino)ethyloxy}-benzoyl]amino-2-(S)-amino-ethyl-sulfonylamino group. Such compounds provide tumor avidity and imaging ability thus permitting selective and clear tumor imaging.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HEALTH RESEARCH INCBUFFALO NY 14263

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Dubey, Shipra Williamsville, US 12 10
Goswami, Lalit Columbia, US 6 8
Oseroff, Allan Buffalo, US 16 154
Pandey, Ravindra K Williamsville, US 61 1021
Pandey, Suresh Buffalo, US 10 16
Pincus, Stephanie Buffalo, US 5 43
Sajjad, Munawwar Clarence Center, US 9 25

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation